Re: $64,000 question no one can answer
Just looking at the landscape in regard to biotechs with taking their own drugs to market, I don't see how you can be so dogmatic as to it is going to be an automatic success. AMRN has barely survived for years and it is only the fact that they may have hit it lucky with their latest study in regard to their fish oil in lower CV risk that will save them. Without it they would end up close to AEGR which by the way did terrible. ALNY might make it but they are first busy losing over $800 million a year. Then there is CORT. How about EXEL, they have had some success. If only they had a chance to talk to you in person to see how it really should have been done. The lion king was bad mouthing IONS when it was in the 60's and promoting LGND when it was in the over $130's, their honesty, their handling of things and so on. Whatever IONS is doing they have $2.2 billion and products that are going to compete. Maybe help churches or other organizations see how they can get more revenues. t